These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8074561)

  • 21. [Lomefloxacin hydrochloride (Maxaquin), a long-acting fluoroquinolone (information for specialists)].
    Kuznetsovoĭ SM
    Antibiot Khimioter; 1998; 43(2):40-1. PubMed ID: 9551172
    [No Abstract]   [Full Text] [Related]  

  • 22. [The future of quinolones].
    Gomis M; Ledesma F
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):463-5. PubMed ID: 9011201
    [No Abstract]   [Full Text] [Related]  

  • 23. Enrofloxacin in salmonids.
    Bowser PR; Babish JG
    Vet Hum Toxicol; 1991; 33 Suppl 1():46-8. PubMed ID: 1926748
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro anti-MAC activities of new quinolones in focus (2)].
    Kawahara S; Eirei J
    Kekkaku; 1996 Sep; 71(9):537-9. PubMed ID: 8999137
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro anti-MAC activities of new quinolones in focus (1)].
    Tsuyuguchi K
    Kekkaku; 1996 Sep; 71(9):536-7. PubMed ID: 8999136
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV
    Urologiia; 2002; (1):11-4. PubMed ID: 11877963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the fluoroquinolones in ophthalmology.
    Serdarevic ON
    Int Ophthalmol Clin; 1993; 33(1):163-78. PubMed ID: 8349424
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
    Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New uses for new and old quinolones and the challenge of resistance.
    Hooper DC
    Clin Infect Dis; 2000 Feb; 30(2):243-54. PubMed ID: 10671323
    [No Abstract]   [Full Text] [Related]  

  • 30. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG; Owens RC; Quintiliani R; Nightingale CH
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fluoroquinolones as antibacterial preparations and their use in the treatment of tuberculosis].
    Vishnevskaia EB; Kocherovets VI; Vishnevskiĭ BI
    Antibiot Khimioter; 2002; 47(6):42-7. PubMed ID: 12422649
    [No Abstract]   [Full Text] [Related]  

  • 33. Resistance of shigella to nalidixic acid & fluorinated quinolones.
    Thirunarayanan MA; Jesudason MV; John TJ
    Indian J Med Res; 1993 Nov; 97():239-41. PubMed ID: 8144205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanisms of bacterial resistance to quinolones].
    Taléns-Visconti R; Garrigues TM; Cantón E
    Rev Esp Quimioter; 2002 Mar; 15(1):25-31. PubMed ID: 12582434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Desfluoroquinolones vs. fluoroquinolones].
    García-Rodríguez JA; Gutiérrez Zufiaurre N
    Rev Esp Quimioter; 2002 Dec; 15(4):303-5. PubMed ID: 12587034
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on cross-resistance of fluoroquinolones.
    Garau J
    Int J Clin Pract Suppl; 2000 Dec; (115):94-8. PubMed ID: 11219309
    [No Abstract]   [Full Text] [Related]  

  • 37. Quinolones: which generation for which microbe?
    Lee MK; Kanatani MS
    West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165
    [No Abstract]   [Full Text] [Related]  

  • 38. [Development of resistance and utilization of fluoroquinolones in a university hospital].
    Vlcek J; Pozlerová E; Lonská V; Kotlár J
    Ceska Slov Farm; 1997 Oct; 46(5):195-8. PubMed ID: 9600142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The importance of fluoroquinolones in treating pneumonia in the elderly].
    Belousov IuB; Efremenkova OV; Sokolov AV; Tishenkova IF
    Antibiot Khimioter; 1999; 44(12):23-6. PubMed ID: 10687030
    [No Abstract]   [Full Text] [Related]  

  • 40. The future of the quinolones.
    Andriole VT
    Drugs; 1993; 45 Suppl 3():1-7. PubMed ID: 7689439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.